Marina Marchowez

Marina Marchowez is a skilled biostatistician with extensive experience in preparing AMNOG and HTA dossiers for the benefit assessment of new drugs, particularly within the German healthcare context. Currently employed at Cytel and UCB, Marina provides strategic statistical input for dossier planning and assesses data from various clinical and observational studies to inform medication positioning. Previous roles include contributions to GSK in biostatistics and epidemiology, as well as internships at Siemens, Wealthcap, and Hopmann, where expertise in data analytics, mathematical modeling, and statistical methodologies was developed. Marina holds a Master of Science in Biostatistics and a Bachelor of Science in Statistics and Computer Science from Ludwig-Maximilians-Universität München.